Leo Ehrlich - 30 Dec 2022 Form 4 Insider Report for Innovation Pharmaceuticals Inc.

Role
CEO and Chairman, Director
Signature
/s/ Leo Ehrlich
Issuer symbol
IPIX on OTC
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:15:14 UTC
Previous filing
28 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPIX Class B Common Stock Other $0 -11,307,527 -72% $0.000000 4,333,936 30 Dec 2022 Class A Common Stock 11,307,527 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, and has no expiration date.
F2 Represents the voluntary surrender, without consideration, to the registrant of 11,307,527 shares of Class B Common Stock.